This inventor holds 1 USPTO granted patent. Top assignee: Nippon Shoji Kaisha Ltd.. Active years: 1981.
Company Filing History:
Years Active: 1981
Title: Yoshikazu Soejima: Innovator in Therapeutic Agents
Introduction
Yoshikazu Soejima is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of therapeutic agents, particularly in treating consciousness disorders and perception and movement issues. His innovative approach has the potential to improve the quality of life for many patients suffering from these conditions.
Latest Patents
Yoshikazu Soejima holds a patent for a therapeutic agent designed to address consciousness disorders and perception and movement disorders. This agent comprises a phosphatidic acid derivative selected from phosphatidylcholine, phosphatidic acid, and phosphatidylethanolamine, combined with a conventional carrier. The therapeutic agent is administered to patients suffering from consciousness disorders, particularly those with post-traumatic syndrome from head injuries or the sequelae of apoplexy or whiplash injuries, preferably through an intravenous route.
Career Highlights
Soejima is associated with Nippon Shoji Kaisha Ltd., where he has been able to apply his expertise in developing innovative therapeutic solutions. His work has garnered attention for its potential impact on medical treatments and patient care.
Collaborations
Yoshikazu Soejima has collaborated with notable colleagues, including Tadashi Nakajima and Kyoji Rikimi. Their combined efforts have contributed to advancements in the field of therapeutic agents.
Conclusion
Yoshikazu Soejima's work in developing therapeutic agents for consciousness disorders showcases his commitment to innovation in medicine. His contributions have the potential to significantly benefit patients facing challenging health issues.